Literature DB >> 18632203

Osteotropic cancers: from primary tumor to bone.

Jeroen T Buijs1, Gabri van der Pluijm.   

Abstract

It has long been recognized that primary cancers spread to distant organs with characteristic preference. Bone metastases occur in approximately 70% of patients with advanced breast and prostate cancer, causing severe morbidity and hospitalization. In the last decade, we have gained a better understanding of the mechanisms by which certain tumor types tend to metastasize specifically to bone. It appears that the interaction between the organ microenvironment and cancer cells is fundamental for establishing metastatic growth. Accordingly, Stephen Paget's 'seed and soil' hypothesis - stating that circulating cancer cells (the 'seeds') disperse in all directions, but can accomplish metastases only in organs where the microenvironment (the 'soil') is permissive for their growth - still holds forth today. For this reason, this review uses the 'seed and soil' hypothesis as a template to discuss novel insight and developments in the bone metastasis field.

Entities:  

Mesh:

Year:  2008        PMID: 18632203     DOI: 10.1016/j.canlet.2008.05.044

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  51 in total

1.  Tissue slice grafts: an in vivo model of human prostate androgen signaling.

Authors:  Hongjuan Zhao; Rosalie Nolley; Zuxiong Chen; Donna M Peehl
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

2.  Normal peripheral prostate stromal cells stimulate prostate cancer development: roles of c-kit signal.

Authors:  Jian-Hua Guo; Juan Zhou; Yang Zhao; Peng-Yue Liu; Hai-Jun Yao; Jun Da; Ming Zhang; Zhe Zhou; Qi Chen; Yu-Bing Peng; Zhong Wang
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

3.  The alpha-receptor for platelet-derived growth factor confers bone-metastatic potential to prostate cancer cells by ligand- and dimerization-independent mechanisms.

Authors:  Mike R Russell; Qingxin Liu; Hetian Lei; Andrius Kazlauskas; Alessandro Fatatis
Journal:  Cancer Res       Date:  2010-05-04       Impact factor: 12.701

4.  From the liver to the foot: a case of systemic embolism and acrometastasis in hepatocellular carcinoma.

Authors:  Ghaith Abu-Zeinah; Dwight Owen; Carlos Prieto-Granada; Natasha Rekhtman; David Klimstra; Dipti Gupta; James Harding; Ghassan K Abou-Alfa
Journal:  Gastrointest Cancer Res       Date:  2014-05

5.  Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo.

Authors:  Irene Zinonos; Agatha Labrinidis; Michelle Lee; Vasilios Liapis; Shelley Hay; Vladimir Ponomarev; Peter Diamond; David M Findlay; Andrew C W Zannettino; Andreas Evdokiou
Journal:  J Bone Miner Res       Date:  2011-03       Impact factor: 6.741

6.  The cancer-related Runx2 protein enhances cell growth and responses to androgen and TGFbeta in prostate cancer cells.

Authors:  Margaretha van der Deen; Jacqueline Akech; Tao Wang; Thomas J FitzGerald; Dario C Altieri; Lucia R Languino; Jane B Lian; Andre J van Wijnen; Janet L Stein; Gary S Stein
Journal:  J Cell Biochem       Date:  2010-03-01       Impact factor: 4.429

Review 7.  Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy.

Authors:  Gagan Deep; Rajesh Agarwal
Journal:  Curr Cancer Drug Targets       Date:  2013-06       Impact factor: 3.428

8.  Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases.

Authors:  Michael H Ross; Alison K Esser; Gregory C Fox; Anne H Schmieder; Xiaoxia Yang; Grace Hu; Dipanjan Pan; Xinming Su; Yalin Xu; Deborah V Novack; Thomas Walsh; Graham A Colditz; Gabriel H Lukaszewicz; Elizabeth Cordell; Joshua Novack; James A J Fitzpatrick; David L Waning; Khalid S Mohammad; Theresa A Guise; Gregory M Lanza; Katherine N Weilbaecher
Journal:  Cancer Res       Date:  2017-08-30       Impact factor: 12.701

9.  Osteoblasts modulate Ca2+ signaling in bone-metastatic prostate and breast cancer cells.

Authors:  Julia D'Ambrosio; Alessandro Fatatis
Journal:  Clin Exp Metastasis       Date:  2009-09-21       Impact factor: 5.150

10.  Abnormal expression, localization and interaction of canonical transient receptor potential ion channels in human breast cancer cell lines and tissues: a potential target for breast cancer diagnosis and therapy.

Authors:  Ebru Aydar; Syn Yeo; Mustafa Djamgoz; Christopher Palmer
Journal:  Cancer Cell Int       Date:  2009-08-18       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.